You have 9 free searches left this month | for more free features.

Condition

Osteogenesis Imperfecta (1)

Plasma Cell Myeloma Refractory (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Sanofi (2)

Collaborator

Intervention

sar439459 (2)

belantamab mafodotin (1)

dexamethasone (1)

isatuximab sar650984 (1)

placebo (1)

pomalidomide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

sar439459

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Osteogenesis Imperfecta Trial in Worldwide (SAR439459, Placebo)

Recruiting

Osteogenesis Imperfecta

SAR439459
Placebo

New Haven, Connecticut
+9 more

Jan 10, 2023

Plasma Cell Myeloma Refractory Trial in Worldwide (Isatuximab SAR650984, Dexamethasone, Pomalidomide)

Recruiting

Plasma Cell Myeloma Refractory

Isatuximab SAR650984
+4 more

Chicago, Illinois
+18 more

Aug 2, 2022